Company Growth (employees)
Radius Health was founded in 2003 and is headquartered in Waltham, US
Key People at Radius Health
Michael Wyzga
President & CEO
Gary Hattersley
Senior Vice President, Preclinical Development
Michael Franken
Senior Vice President, Chief Business Officer
Radius Health Office Locations
Radius Health has an office in Waltham
Waltham, US (HQ)
950 Winter St
Radius Health Data and Metrics
Radius Health Financial Metrics
USD
Net income (Q1, 2017) | (56.9 m) |
EBIT (Q1, 2017) | (57.6 m) |
Market capitalization (17-Aug-2017) | 1.5 b |
Cash (31-Mar-2017) | 174.6 m |
Radius Health's current market capitalization is $1.5 b.
| USD | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 |
|---|---|---|---|---|
R&D expense | 107.4 m | |||
General and administrative expense | 77.5 m | |||
Operating expense total | 184.9 m | |||
EBIT | (67.4 m) | (59.4 m) | (99.1 m) | (184.9 m) |
Interest income | 2.4 m | |||
Net Income | (60.7 m) | (62.5 m) | (101.5 m) | (182.8 m) |
| USD | Q2, 2015 | Q3, 2015 | Q1, 2016 | Q2, 2016 | Q3, 2016 | Q1, 2017 |
|---|---|---|---|---|---|---|
R&D expense | 16.3 m | 18.2 m | 27.5 m | 26.9 m | 27.5 m | 19.5 m |
General and administrative expense | 6 m | 8.5 m | 13.6 m | 17.2 m | 19.2 m | 38.1 m |
Operating expense total | 22.3 m | 26.7 m | 41.1 m | 44.1 m | 46.7 m | 57.6 m |
EBIT | (22.3 m) | (26.7 m) | (41.1 m) | (44.1 m) | (46.7 m) | (57.6 m) |
Interest expense | (794 k) | (294 k) | (797 k) | |||
Interest income | 185 k | 274 k | 667 k | 744 k | 585 k | 607 k |
Net Income | (23 m) | (28.3 m) | (40.5 m) | (43.4 m) | (46.2 m) | (56.9 m) |
| USD | FY, 2013 | FY, 2016 |
|---|---|---|
Cash | 12.3 m | 258.6 m |
Accounts Receivable | 28.3 m | |
Inventories | 334 k | 2.3 m |
Current Assets | 12.6 m | 334.8 m |
PP&E | 76 k | 4.9 m |
Total Assets | 12.8 m | 340.3 m |
Accounts Payable | 300 k | 6.1 m |
Current Liabilities | 35.3 m | 32.7 m |
Total Liabilities | 33.1 m | |
Preferred Stock | 43.9 m | |
Additional Paid-in Capital | 935.7 m | |
Retained Earnings | (277.3 m) | (628.6 m) |
Total Equity | (277.3 m) | 307.2 m |
Financial Leverage | 0 x | 1.1 x |
| USD | Q1, 2016 | Q2, 2016 | Q3, 2016 | Q1, 2017 |
|---|---|---|---|---|
Cash | 104.4 m | 120.6 m | 198.6 m | 174.6 m |
Current Assets | 440.1 m | 406.1 m | 373.5 m | 288.7 m |
PP&E | 2.2 m | 2.9 m | 4.1 m | 6.1 m |
Total Assets | 445.1 m | 409.4 m | 378.1 m | 295.4 m |
Accounts Payable | 3.8 m | 3 m | 2.7 m | 6.7 m |
Current Liabilities | 18.9 m | 19.6 m | 25.3 m | 33 m |
Additional Paid-in Capital | 912.2 m | 919.3 m | 928.2 m | 947 m |
Retained Earnings | (486.2 m) | (529.7 m) | (575.8 m) | (685 m) |
Total Equity | 426.2 m | 389.9 m | 352.4 m | 262.1 m |
Financial Leverage | 1 x | 1.1 x | 1.1 x | 1.1 x |
| USD | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 |
|---|---|---|---|---|
Net Income | (60.7 m) | (101.5 m) | (182.8 m) | |
Depreciation and Amortization | 27 k | 586 k | ||
Inventories | 1.7 m | 2.1 m | 7 m | 4.6 m |
Accounts Payable | (250 k) | 2.3 m | 6.2 m | (100 k) |
Cash From Operating Activities | (45 m) | 16.2 m | 131.2 m | (139.8 m) |
Purchases of PP&E | (2 k) | (2.9 m) | ||
Cash From Investing Activities | 4 m | 236.1 m | ||
Cash From Financing Activities | 34.7 m | 2.6 m | ||
Interest Paid | 1.8 m |
| USD | Q2, 2014 | Q3, 2014 | Q1, 2015 | Q2, 2015 | Q3, 2015 | Q1, 2016 | Q2, 2016 | Q3, 2016 | Q1, 2017 |
|---|---|---|---|---|---|---|---|---|---|
Net Income | (23 m) | (28.3 m) | (40.5 m) | (43.4 m) | (46.2 m) | (56.9 m) | |||
Accounts Payable | 1.2 m | 1.3 m | 3.2 m | 3.3 m | 4.5 m | 3.8 m | 3 m | 2.7 m | 6.7 m |
| Y, 2017 | |
|---|---|
Financial Leverage | 1.1 x |
Radius Health Market Value History
Market Position of Radius Health
Traffic Overview of Radius Health
Radius Health Online and Social Media Presence
Radius Health News and Updates
August 16, 2016
Osteoporosis, a Disease With Few Treatment Options, May Soon Have One More
A clinical trial found that a new drug stimulates bone growth and prevents fractures at least as well as the only other such drug on the market.